Cookie policy

This site uses cookies to improve your user experience. By using this website, you agree that we can place cookies on your device. For further information, please read our Privacy And Cookies Policy

I accept the terms and conditions
Skip Ribbon Commands
Skip to main content

Stents

Products

 

 

Ultimaster Clinical Programhttps://www.terumo-europe.com/en-emea/the-comprehensive-clinical-programmeUltimaster Clinical ProgramHayabusaArticlePage
CENTURY II Trialhttps://www.terumo-europe.com/en-emea/clinicaldata/century-iiCENTURY II Trial<ul><li>Multicentre, intercontinental study: 58 sites in 13 countries across Europe, Japan, and South Korea </li><li>Primary endpoint: freedom from TLF at 9 months</li><li>Secondary endpoint: rate of TVF; patient-oriented composite endpoint; rate of TLR, TVR, ST, cardiac death, MI; composite of cardiac death and MI; rate of bleeding and vascular complications </li><li>Clinical follow-up up to 5 years </li><li>Stage: Published and completed<br></li></ul>HayabusaArticlePage
DISCOVERY 1TO3 Trialhttps://www.terumo-europe.com/en-emea/clinicaldata/discovery-1to3-trialDISCOVERY 1TO3 Trial60 MVD patients with OFDI, single arm, primary endpoint TLF @ 12M. PublishedHayabusaArticlePage

 

 

 

 

 

 

Terumo to Launch the Ultimaster Tansei Drug Eluting Stent in Europehttps://www.terumo-europe.com/en-emea/news/terumo-to-launch-the-ultimaster-tansei-drug-eluting-stent-in-europeTerumo to Launch the Ultimaster Tansei Drug Eluting Stent in EuropeTokyo, Japan23/05/2018 22:00:00
Terumo receives CE Mark for Ultimaster TANSEI drug-eluting stenthttps://www.terumo-europe.com/en-emea/news/terumo-receives-ce-mark-for-ultimaster-tansei-drug-eluting-stentTerumo receives CE Mark for Ultimaster TANSEI drug-eluting stentLeuven, Belgium22/04/2018 22:00:00
First patient enrolled in major new study investigating abbreviated DAPT post-stent in high bleeding risk patientshttps://www.terumo-europe.com/en-emea/news/first-patient-enrolled-in-major-new-study-investigating-abbreviated-dapt-post-stent-in-high-bleeding-risk-patientsFirst patient enrolled in major new study investigating abbreviated DAPT post-stent in high bleeding risk patientsEmmen, The Netherlands03/04/2017 22:00:00